Tissue Polypeptide Specific Antigen (TPS) as a Tumor Marker in Renal Cell Carcinoma

CMUR > College of Medicine > School of Medicine > Journal articles > Item 310903500/3631

Please use this identifier to cite or link to this item: http://ir.cmu.edu.tw/ir/handle/310903500/3631

Title:	Tissue Polypeptide Specific Antigen (TPS) as a Tumor Marker in Renal Cell Carcinoma
Authors:	張兆祥(Chao-Hsiang Chang);吳錫金(Wu,Hsi-Chin);(Ruoh-Fang Yeh);高嘉鴻(Chia-Hung Kao)*;林正介(Cheng-Chieh Lin);李正淳(Cheng-Chun Lee)
Contributors:	醫學院醫學系學士班泌尿學科;中國附醫泌尿部
Date:	2002-09
Issue Date:	2009-08-20 18:48:44 (UTC+8)
Abstract:	Tissue polypeptide specific antigen (TPS) is a new tumor marker that indicates tumor proliferative rate rather than tumor burden. The purpose of this study was to assess the clinical value of TPS in patients with renal cell carcinoma (RCC). Serum levels of TPS were measured in 30 patients with locoregional and in 20 patients with advanced disease before and after therapy. The results showed that: (1) the detection sensitivity of TPS for RCC is 60.0%; (2) the detection sensitivity of TPS in advanced RCC (100.0%) was significantly higher than in locoregional RCC (33.3%); (3) the 10 locoregional RCC patients without recurrence had normal serum TPS levels during a follow-up period of 1 year; and (4) the 8 advanced RCC patients with good response during therapy had normal serum TPS levels, while 12 patients with poor disease had significantly elevated serum TPS levels during a follow-up period of 1 year. Our results suggest that TPS may have a potential clinical role as a valuable tumor marker for RCC, especially in advanced diseases and follow-up therapy response.
Relation:	ANTICANCER RESEARCH 22(5):2949~2950
Appears in Collections:	[School of Medicine] Journal articles

Files in This Item:

File	Size	Format
	58Kb	Unknown	338	View/Open

Loading...